Biotricity Stock Number Of Employees

BTCY Stock

USD 0.87 0.06 6.45%

Biotricity fundamentals help investors to digest information that contributes to Biotricity's financial success or failures. It also enables traders to predict the movement of Biotricity Stock. The fundamental analysis module provides a way to measure Biotricity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotricity stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biotricity Company Number Of Employees Analysis

Biotricity's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Number of Employees

Full Time

+

Part Time

More About Number Of Employees | All Equity Analysis

Current Biotricity Number Of Employees

Most of Biotricity's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotricity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biotricity Number Of Employees Driver Correlations

Understanding the fundamental principles of building solid financial models for Biotricity is extremely important. It helps to project a fair market value of Biotricity Stock properly, considering its historical fundamentals such as Number Of Employees. Since Biotricity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biotricity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biotricity's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Short Term Investments	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Property Plant Equipment	Long Term Debt	Capital Surpluse	Deferred Long Term Liab
Total Assets		-0.49	0.61	0.53	-0.81	0.57	0.89	0.76	0.97	0.57	0.7	-0.3	0.68	-0.37	0.53	0.59	0.25	0.8	0.8	0.83	-0.37	-0.37
Total Stockholder Equity	-0.49		-0.67	-0.97	0.85	-0.97	-0.75	-0.93	-0.31	-0.94	-0.69	0.38	-0.95	0.66	-0.95	0.37	0.65	-0.82	-0.81	-0.8	0.66	0.66
Current Deferred Revenue	0.61	-0.67		0.65	-0.88	0.76	0.77	0.75	0.5	0.81	0.89	-0.49	0.75	-0.49	0.73	-0.07	-0.36	0.65	0.62	0.62	-0.49	-0.49
Net Debt	0.53	-0.97	0.65		-0.83	0.98	0.75	0.95	0.33	0.9	0.63	-0.21	0.96	-0.79	0.91	-0.29	-0.56	0.85	0.89	0.85	-0.79	-0.79
Retained Earnings	-0.81	0.85	-0.88	-0.83		-0.89	-0.94	-0.94	-0.7	-0.9	-0.91	0.48	-0.92	0.52	-0.85	-0.06	0.31	-0.89	-0.85	-0.88	0.52	0.52
Accounts Payable	0.57	-0.97	0.76	0.98	-0.89		0.79	0.96	0.38	0.94	0.74	-0.32	0.96	-0.77	0.93	-0.27	-0.55	0.85	0.88	0.84	-0.77	-0.77
Net Receivables	0.89	-0.75	0.77	0.75	-0.94	0.79		0.91	0.8	0.85	0.8	-0.51	0.9	-0.54	0.83	0.18	-0.2	0.87	0.82	0.85	-0.54	-0.54
Total Liab	0.76	-0.93	0.75	0.95	-0.94	0.96	0.91		0.6	0.93	0.77	-0.37	0.98	-0.72	0.92	-0.04	-0.38	0.92	0.93	0.92	-0.72	-0.72
Total Current Assets	0.97	-0.31	0.5	0.33	-0.7	0.38	0.8	0.6		0.41	0.66	-0.3	0.5	-0.13	0.35	0.72	0.4	0.7	0.64	0.73	-0.13	-0.13
Short Term Debt	0.57	-0.94	0.81	0.9	-0.9	0.94	0.85	0.93	0.41		0.77	-0.57	0.95	-0.69	0.99	-0.31	-0.63	0.79	0.75	0.74	-0.69	-0.69
Common Stock	0.7	-0.69	0.89	0.63	-0.91	0.74	0.8	0.77	0.66	0.77		-0.55	0.73	-0.3	0.69	0.09	-0.23	0.79	0.66	0.75	-0.3	-0.3
Net Tangible Assets	-0.3	0.38	-0.49	-0.21	0.48	-0.32	-0.51	-0.37	-0.3	-0.57	-0.55		-0.36	0.08	-0.52	0.11	0.33	-0.22	-0.07	-0.14	0.08	0.08
Short Term Investments	0.68	-0.95	0.75	0.96	-0.92	0.96	0.9	0.98	0.5	0.95	0.73	-0.36		-0.74	0.95	-0.18	-0.51	0.89	0.88	0.87	-0.74	-0.74
Long Term Investments	-0.37	0.66	-0.49	-0.79	0.52	-0.77	-0.54	-0.72	-0.13	-0.69	-0.3	0.08	-0.74		-0.71	0.27	0.41	-0.52	-0.7	-0.52	1.0	1.0
Short Long Term Debt	0.53	-0.95	0.73	0.91	-0.85	0.93	0.83	0.92	0.35	0.99	0.69	-0.52	0.95	-0.71		-0.37	-0.67	0.78	0.73	0.72	-0.71	-0.71
Net Invested Capital	0.59	0.37	-0.07	-0.29	-0.06	-0.27	0.18	-0.04	0.72	-0.31	0.09	0.11	-0.18	0.27	-0.37		0.92	0.12	0.16	0.21	0.27	0.27
Net Working Capital	0.25	0.65	-0.36	-0.56	0.31	-0.55	-0.2	-0.38	0.4	-0.63	-0.23	0.33	-0.51	0.41	-0.67	0.92		-0.2	-0.13	-0.11	0.41	0.41
Capital Stock	0.8	-0.82	0.65	0.85	-0.89	0.85	0.87	0.92	0.7	0.79	0.79	-0.22	0.89	-0.52	0.78	0.12	-0.2		0.92	0.98	-0.52	-0.52
Property Plant Equipment	0.8	-0.81	0.62	0.89	-0.85	0.88	0.82	0.93	0.64	0.75	0.66	-0.07	0.88	-0.7	0.73	0.16	-0.13	0.92		0.96	-0.7	-0.7
Long Term Debt	0.83	-0.8	0.62	0.85	-0.88	0.84	0.85	0.92	0.73	0.74	0.75	-0.14	0.87	-0.52	0.72	0.21	-0.11	0.98	0.96		-0.52	-0.52
Capital Surpluse	-0.37	0.66	-0.49	-0.79	0.52	-0.77	-0.54	-0.72	-0.13	-0.69	-0.3	0.08	-0.74	1.0	-0.71	0.27	0.41	-0.52	-0.7	-0.52		1.0
Deferred Long Term Liab	-0.37	0.66	-0.49	-0.79	0.52	-0.77	-0.54	-0.72	-0.13	-0.69	-0.3	0.08	-0.74	1.0	-0.71	0.27	0.41	-0.52	-0.7	-0.52	1.0

Click cells to compare fundamentals

Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.

Competition

Predict Biotricity

Based on the recorded statements, Biotricity is currently employing 55 people. This is 99.5% lower than that of the Health Care Equipment & Supplies sector and 99.27% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.71% higher than that of the company.

Biotricity Number Of Employees Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotricity's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotricity could also be used in its relative valuation, which is a method of valuing Biotricity by comparing valuation metrics of similar companies.

Biotricity is currently under evaluation in number of employees category among its peers.

Biotricity Current Valuation Drivers

We derive many important indicators used in calculating different scores of Biotricity from analyzing Biotricity's financial statements. These drivers represent accounts that assess Biotricity's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biotricity's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	5.1M	5.8M	15.0M	17.2M	4.0M	11.8M
Enterprise Value	5.9M	7.2M	17.5M	20.5M	23.0M	11.4M

Biotricity Fundamentals

	Return On Equity	-41.01
	Return On Asset	-0.95
	Profit Margin	(1.25) %
	Operating Margin	(0.43) %
	Current Valuation	32.62 M
	Shares Outstanding	20.39 M
	Shares Owned By Insiders	12.05 %
	Shares Owned By Institutions	3.13 %
	Number Of Shares Shorted	618.4 K
	Price To Earning	(6.70) X
	Price To Book	33.02 X
	Price To Sales	0.94 X
	Revenue	9.64 M
	Gross Profit	4.57 M
	EBITDA	(15.59 M)
	Net Income	(18.66 M)
	Cash And Equivalents	2.89 M
	Cash Per Share	0.05 X
	Total Debt	19.55 M
	Debt To Equity	6.45 %
	Current Ratio	1.54 X
	Book Value Per Share	(2.95) X
	Cash Flow From Operations	(13.55 M)
	Short Ratio	5.07 X
	Earnings Per Share	(1.75) X
	Target Price	4.0
	Number Of Employees	55
	Beta	1.41
	Market Capitalization	17.83 M
	Total Asset	6.51 M
	Retained Earnings	(112.57 M)
	Working Capital	(6.44 M)
	Current Asset	11 K
	Current Liabilities	303 K
	Net Asset	6.51 M

About Biotricity Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biotricity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotricity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotricity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

QUAL	iShares MSCI USA
CGDV	Capital Group Dividend
SCHG	Schwab Large Cap Growth

Additional Tools for Biotricity Stock Analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC